Point72 Asia Singapore Pte. Ltd. Makes New $170,000 Investment in The Clorox Company (NYSE:CLX)

Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of The Clorox Company (NYSE:CLX) during the fourth quarter, Holdings Channel.com reports. The fund purchased 1,049 shares of the company’s stock, valued at approximately $170,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Fifth Third Wealth Advisors LLC acquired a new position in shares of Clorox in the 4th quarter worth approximately $204,000. Hennion & Walsh Asset Management Inc. grew its stake in shares of Clorox by 80.4% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 4,372 shares of the company’s stock worth $710,000 after purchasing an additional 1,949 shares during the last quarter. Avanza Fonder AB acquired a new position in shares of Clorox in the 4th quarter worth approximately $2,245,000. Wealthcare Advisory Partners LLC grew its stake in shares of Clorox by 22.4% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 1,590 shares of the company’s stock worth $258,000 after purchasing an additional 291 shares during the last quarter. Finally, Wedge Capital Management L L P NC acquired a new position in shares of Clorox in the 4th quarter worth approximately $3,468,000. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CLX has been the topic of several recent research reports. Barclays lowered their price objective on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating on the stock in a research note on Wednesday, May 7th. Morgan Stanley lowered their price objective on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. UBS Group dropped their target price on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating on the stock in a research report on Thursday, April 17th. Wells Fargo & Company dropped their target price on shares of Clorox from $145.00 to $142.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 6th. Finally, DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $151.23.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of Clorox stock in a transaction dated Wednesday, May 7th. The stock was acquired at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the purchase, the director now owns 4,000 shares of the company’s stock, valued at $546,280. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 0.57% of the stock is owned by corporate insiders.

Clorox Stock Performance

Shares of CLX opened at $136.31 on Friday. The company’s 50 day moving average price is $141.05 and its 200 day moving average price is $153.35. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a market capitalization of $16.80 billion, a PE ratio of 37.24, a PEG ratio of 2.62 and a beta of 0.60. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94.

Clorox (NYSE:CLX) last posted its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. Clorox’s revenue was down 8.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.71 earnings per share. Research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd were paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.58%. The ex-dividend date was Wednesday, April 23rd. Clorox’s payout ratio is 87.61%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.